Study guide
14.3 Progestin-Only Methods & Emergency Contraception
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
14.3 Progestin-Only Methods & Emergency Contraception
Key Takeaways Explain This Topic AI
Norethindrone progestin-only pills require dosing within a 3-hour window with 48 hours of backup if late, while drospirenone allows a 24-hour window.
Depot medroxyprogesterone is given every 13 weeks with a 2-week grace period, and return of fertility averages 9 to 10 months after the last injection.
The copper IUD is the most effective emergency contraception, exceeding 99 percent, and can be placed up to 5 days after intercourse or ovulation.
Ulipristal acetate is more effective than levonorgestrel, especially closer to ovulation and at higher body weight, and works up to 120 hours.
Progestin-containing contraception must not be started for 5 days after ulipristal, because progestin blunts the selective progesterone receptor modulator effect.
Last updated: September 2026
Progestin-Only Pills (POPs) & Injectable Contraception
Progestin-only contraceptives provide safe, highly effective alternatives for individuals with medical contraindications to estrogen (e.g., smokers aged ≥35, hypertension, migraine with aura, thromboembolic history).
1. Progestin-Only Pills (POPs)
Traditional Norethindrone (0.35 mg daily):
Mechanism: Thickens cervical mucus within 2 to 4 hours of ingestion (forming an impassable barrier to sperm) and causes endometrial thinning. It does NOT reliably suppress ovulation (ovulation occurs in ~50% of cycles).
The Strict 3-Hour Window: The cervical mucus thickening effect wanes significantly after 22 to 24 hours. If a dose is delayed by more than 3 hours (>27 hours since last dose) : take the missed pill immediately, take the next pill at the regular time, and use back-up barrier contraception for 48 hours .
Drospirenone (Slynd: 4 mg daily, 24 active / 4 inert):
Mechanism: Reliably suppresses ovulation ; allows a 24-hour missed pill window (identical flexibility to COCs). Demonstrates mild anti-mineralocorticoid activity (monitor serum potassium if co-administered with ACE inhibitors, ARBs, or potassium-sparing diuretics).
2. Depot Medroxyprogesterone Acetate (DMPA / Depo-Provera)
Dosing & Administration: 150 mg intramuscularly (deltoid or ventrogluteal muscle) or 104 mg subcutaneously every 13 weeks . The CDC allows a grace period of up to 15 weeks from the last injection without requiring additional contraceptive precautions or pregnancy exclusion.
Mechanism of Action: High-dose systemic progestin exerts potent negative feedback on the HPO axis, suppressing GnRH and the mid-cycle LH surge to reliably abolish ovulation . Induces marked endometrial atrophy and cervical mucus thickening.
Clinical Benefits: High efficacy (typical failure rate 4%); amenorrhea in 50% by 1 year and 70% by 2 years ; marked reduction in dysmenorrhea; reduces endometrial cancer risk by 80% ; decreases vaso-occlusive crises in patients with sickle cell disease; reduces epileptic seizure frequency.
Bone Mineral Density (BMD) Loss & ACOG/CDC Guidance: The FDA Black Box Warning notes loss of BMD with prolonged use due to hypoestrogenism. However, extensive clinical trials confirm that bone mineral density loss is substantially or completely reversible after discontinuation , returning to baseline levels. Both ACOG and the CDC state that DMPA use should NOT be restricted to 2 years , and routine monitoring of BMD with DEXA scans is strictly not recommended .
Delayed Return of Fertility: Ovulatory suppression persists beyond the 13-week interval; the median time to conception following DMPA discontinuation is 9 to 18 months (average ~10 months) . Crucial anticipatory counseling for patients desiring pregnancy in the near future.
Emergency Contraception (EC)
Emergency contraception prevents pregnancy following unprotected intercourse, sexual assault, or contraceptive failure (e.g., condom rupture, missed oral pills, dislodged diaphragm). Emergency Contraception Options & Clinical Selection
- ├── 1. Intrauterine Devices (Most Effective EC - Failure Rate <0.1%)
- │ ├── Copper IUD (ParaGard) ──> Insert up to 120 Hours (5 Days) post-coitus
- │ └── 52 mg Levonorgestrel IUD (Mirena/Liletta) ──> Insert up to 120 Hours post-coitus
- │ └── Provides immediate, continuous top-tier LARC contraception for 8-12 years
- ├── 2. Ulipristal Acetate (Ella 30 mg Oral - Preferred Oral EC in BMI >30 kg/m²)
- │ ├── Selective Progesterone Receptor Modulator (SPRM) ──> Effective up to 120 Hours
- │ ├── Delays follicular rupture even AFTER the LH surge has started to rise
- │ └── DRUG INTERACTION: Delay starting regular hormonal contraception for 5 DAYS
- ├── 3. Levonorgestrel (Plan B One-Step 1.5 mg Oral - Best within 72 Hours)
- │ ├── Over-the-counter without age/prescription restrictions ──> Effective up to 72 Hours
- │ ├── Ineffective once LH surge has begun; reduced efficacy if BMI >25-30 kg/m²
- │ └── Start regular hormonal contraception immediately ("Quick Start") + 7-day backup
- └── 4. Yuzpe Method (Combined Estrogen-Progestin Pills - Lowest Efficacy / Nausea)
- └── 100 mcg Ethinyl Estradiol + 0.5 mg Levonorgestrel repeated in 12 hours
- Clinical Comparison of Emergency Contraceptive Regimens
Regimen Timing Window Mechanism of Action Efficacy & Weight Limitations Immediate Contraceptive Initiation Rule
Copper IUD (ParaGard) Up to 120 hours (5 days) post-coitus Direct spermicidal action; prevents fertilization >99.9% effective ; efficacy unaffected by patient BMI or body weight Remains in place; provides immediate ongoing Tier 1 contraception for 10–12 years.
52 mg LNG-IUD (Mirena / Liletta) Up to 120 hours (5 days) post-coitus Endometrial decidualization, cervical mucus thickening Non-inferior to Copper IUD for EC; unaffected by body weight Remains in place; provides immediate ongoing Tier 1 contraception for 8 years.
Ulipristal Acetate (Ella, 30 mg PO) Up to 120 hours (5 days) post-coitus Delays or inhibits ovulation; effective even during the early LH surge up to the LH peak Higher efficacy than oral LNG between 72–120 hours; superior efficacy in individuals with BMI >30 kg/m² (or weight >75 kg / 165 lbs) Must WAIT 5 DAYS before starting progestin-containing birth control (progestins impair Ella's antiprogestin action); use barrier backup for 14 days.
Levonorgestrel (Plan B One-Step, 1.5 mg PO) Up to 72 hours (marginal efficacy 72–120h) Delays LH surge prior to onset; ineffective once LH surge begins High efficacy if taken early; efficacy drops significantly when BMI exceeds 25 kg/m² (ineffective in BMI >30 kg/m²) Start regular hormonal contraception immediately on the same day ("Quick Start"); use barrier backup for 7 days.
Yuzpe Regimen Up to 72 hours High-dose estrogen/progestin delays ovulation Lowest efficacy (~75%); high incidence of severe nausea (50%) and emesis (20%) Used only when dedicated EC is inaccessible; co-prescribe oral antiemetic (meclizine or ondansetron).